Funds support local vaccine-making

Vietnam and other countries are in line to get their own vaccine manufacturing capabilities, thanks to PATH, the Program for Appropriate Technology in Health. The international nonprofit is receiving $8 million from HHS's Biomedical Advanced Research and Development Authority to assist in the production and clinical development of influenza vaccines, a step toward building local production capacity in developing countries. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.